ImmuCell Corporation
ICCC
$9.67
-$0.10-1.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.85M | -139.70K | 501.90K | 1.45M | 514.60K |
| Total Depreciation and Amortization | 706.30K | 679.10K | 668.20K | 676.00K | 673.80K |
| Total Amortization of Deferred Charges | 3.20K | 29.60K | 10.80K | 10.80K | 10.80K |
| Total Other Non-Cash Items | 2.84M | -92.60K | 20.80K | 19.10K | 32.30K |
| Change in Net Operating Assets | -215.00K | -1.66M | 399.80K | -579.00K | -1.23M |
| Cash from Operations | 482.50K | -1.18M | 1.60M | 1.57M | -3.10K |
| Capital Expenditure | -172.30K | -593.90K | -155.20K | -329.10K | -196.20K |
| Sale of Property, Plant, and Equipment | 5.00K | 1.90K | 29.20K | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -167.30K | -592.00K | -125.90K | -329.10K | -196.20K |
| Total Debt Issued | 0.00 | 801.30K | -- | -- | -- |
| Total Debt Repaid | -394.60K | -1.12M | -381.40K | -380.10K | -374.20K |
| Issuance of Common Stock | 0.00 | 0.00 | 329.90K | 19.40K | 539.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -14.60K | -24.90K | -43.00K | -16.20K |
| Cash from Financing | -394.60K | -337.70K | -76.40K | -403.60K | 148.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.40K | -2.11M | 1.40M | 841.10K | -50.40K |